Basics 89bio, Inc. Common Stock IPO Date: November 19, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.32B Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 3.42% Avg Daily Range (30 D): $0.22 | 2.38% Avg Daily Range (90 D): $0.24 | 2.67% Institutional Daily Volume Avg Daily Volume: .83M Avg Daily Volume (30 D): 1.23M Avg Daily Volume (90 D): 1.5M Trade Size Avg Trade Size (Sh.): 94 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 85 Institutional Trades Total Inst.Trades: 1,250 Avg Inst. Trade: $2.08M Avg Inst. Trade (30 D): $2.47M Avg Inst. Trade (90 D): $2.14M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.42M Avg Closing Trade (30 D): $1.55M Avg Closing Trade (90 D): $2M Avg Closing Volume: 218.37K     News Aug 8, 2025 @ 2:38 AM 89bio (ETNB) Q2 R&D Jumps 131% Source: Jesterai Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight Nov 29, 2024 @ 6:30 PM 89bio Announces Inducement Grants Under Nasdaq Lis... Source: N/A Nov 13, 2024 @ 4:58 AM 89bio, Inc. Announces Upsized Pricing of $125.0 Mi... Source: 89Bio, Inc. Jun 14, 2024 @ 8:05 PM 89bio Announces Inducement Grants Under Nasdaq Lis... Source: 89bio, Inc. Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.71 $-.49 $-1.39 Diluted EPS $-.71 $-.49 $-1.39 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -111.5M $ -71.28M $ -149.07M Operating Income / Loss $ -115.82M $ -75.91M $ -151.94M Cost of Revenue $ $ $ Net Cash Flow $ -186.32M $ 189.34M $ -120.81M PE Ratio